MIMS March Prescribing Update

- Aubagio (teriflunomide) an oral immunomodulatory agent with anti-inflammatory properties that selectively and reversibly inhibits the mitochondrial enzyme dihydroorotate dehydrogenase (DHO-DH), required for de novo pyrimidine synthesis.